These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 9667731
1. Rapid detection of K-ras gene mutations in canine lung cancer using single-strand conformational polymorphism analysis. Griffey SM, Kraegel SA, Madewell BR. Carcinogenesis; 1998 Jun; 19(6):959-63. PubMed ID: 9667731 [Abstract] [Full Text] [Related]
2. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J, Horáková I, Novotná H, Opáalka P, Roubková H. Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [Abstract] [Full Text] [Related]
3. K-ras activation in non-small cell lung cancer in the dog. Kraegel SA, Gumerlock PH, Dungworth DL, Oreffo VI, Madewell BR. Cancer Res; 1992 Sep 01; 52(17):4724-7. PubMed ID: 1324792 [Abstract] [Full Text] [Related]
4. Molecular analysis of p53 and K-ras in lung carcinomas of coal miners. Sarkar FH, Li Y, Vallyathan V. Int J Mol Med; 2001 Oct 01; 8(4):453-9. PubMed ID: 11562787 [Abstract] [Full Text] [Related]
5. K-ras mutations in 239PuO2 canine lung neoplasms. Griffey SM, Kraegel SA, Weller RE, Watson CR, Madewell BR. Cancer Lett; 1998 Oct 23; 132(1-2):1-5. PubMed ID: 10397446 [Abstract] [Full Text] [Related]
6. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Oncogene; 1990 Jul 23; 5(7):1037-43. PubMed ID: 2197591 [Abstract] [Full Text] [Related]
9. Similar incidence of K-ras mutations in lung carcinomas of FVB/N mice and FVB/N mice carrying a mutant p53 transgene. Shafarenko M, Mahler J, Cochran C, Kisielewski A, Golding E, Wiseman R, Goodrow T. Carcinogenesis; 1997 Jul 23; 18(7):1423-6. PubMed ID: 9230291 [Abstract] [Full Text] [Related]
10. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P. Cancer Epidemiol Biomarkers Prev; 1999 Apr 23; 8(4 Pt 1):297-302. PubMed ID: 10207632 [Abstract] [Full Text] [Related]
12. Molecular screening for somatic mutations in corticotropic adenomas of dogs with pituitary-dependent hyperadrenocorticism. van Wijk PA, Rijnberk A, Croughs RJ, Meij BP, van Leeuwen IS, Sprang EP, Mol JA. J Endocrinol Invest; 1997 Jan 23; 20(1):1-7. PubMed ID: 9075064 [Abstract] [Full Text] [Related]
18. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident. Nikiforov YE, Nikiforova MN, Gnepp DR, Fagin JA. Oncogene; 1996 Aug 15; 13(4):687-93. PubMed ID: 8761289 [Abstract] [Full Text] [Related]
19. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black. Swafford DS, Nikula KJ, Mitchell CE, Belinsky SA. Carcinogenesis; 1995 May 15; 16(5):1215-21. PubMed ID: 7539340 [Abstract] [Full Text] [Related]
20. K-ras exon 2 point mutations in human endometrial cancer. Semczuk A, Schneider-Stock R, Berbec H, Marzec B, Jakowicki JA, Roessner A. Cancer Lett; 2001 Mar 26; 164(2):207-12. PubMed ID: 11179836 [Abstract] [Full Text] [Related] Page: [Next] [New Search]